Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary presents mixed signals. Positive elements include strong margins, productivity gains, and strategic positioning in the healthcare and automotive segments. However, concerns arise from flat organic sales, construction market weakness, and uncertainties related to Middle East logistics. The Q&A section revealed management's avoidance of addressing potential demand destruction. These factors balance out, suggesting a neutral stock price reaction.
Net Sales $1.7 billion, up 4% year-over-year (2% organic sales growth and 2% benefit from currency). Growth driven by strength in healthcare and aerospace, partially offset by softness in construction markets and logistics disruptions due to the Middle East conflict.
Operating EBITDA $414 million, up 15% year-over-year. Margin expanded to 24.6%, an increase of 230 basis points. Growth attributed to organic sales growth, favorable mix, and productivity.
Transaction-Adjusted Free Cash Flow $147 million with a conversion rate of 65%. No specific reasons for change mentioned.
Adjusted EPS $0.55, up 53% year-over-year. On a pro-forma basis, adjusted EPS increased 20%, driven by higher segment earnings, lower tax rate, share count, and exchange gains and losses.
Healthcare & Water Technologies Net Sales $806 million, up 6% year-over-year (3% organic growth and 3% benefit from currency). Growth led by strength in medical packaging and biopharma, partially offset by logistics disruptions in the Middle East.
Healthcare & Water Technologies Operating EBITDA $244 million, up 9% year-over-year. Margin increased to 30.3%, an increase of 110 basis points. Growth driven by organic growth, favorable mix, and productivity gains.
Diversified Industrials Net Sales $875 million, up 3% year-over-year (3% benefit from currency). Organic sales were flat. Growth in aerospace and automotive offset by declines in construction and printing/packaging markets.
Diversified Industrials Operating EBITDA $200 million, up 8% year-over-year. Margin expanded to 22.9%, an increase of 110 basis points. Growth attributed to favorable mix and productivity.
New Product Launches: Introduced upgraded FilmTec nanofiltration elements for municipalities and drinking water utilities, focusing on high-quality water production with lower energy consumption and reduced operating costs.
AI Collaboration: Collaborated with Uncountable, an AI-driven platform, to accelerate product development, improve cycle times, and enhance digital innovation.
Healthcare & Water Technologies Growth: Healthcare sales grew high single digits, driven by medical packaging and biopharma. Water sales faced disruptions in the Middle East but showed strength in industrial water and microelectronics markets.
Diversified Industrials Growth: Aerospace and automotive sectors showed growth, while construction markets remained weak.
Operational Excellence: Improved asset reliability, equipment effectiveness, and on-time delivery through maintenance initiatives, lean execution, and Kaizen activities.
Digital and AI Integration: Expanded use of data-enabled tools for maintenance, defect detection, and asset performance optimization, leading to cost and productivity benefits.
Sustainability Goals: Announced 2035 sustainability goals focusing on sustainable innovation, resilient operations, and community impact, including climate action and renewable energy use.
Capital Allocation: Launched a $275 million accelerated share repurchase program to return cash to shareholders.
Logistics disruptions due to Middle East conflict: The conflict in the Middle East has caused logistics disruptions, particularly impacting sales in the Water business. This has led to challenges in delivering products and maintaining consistent sales in affected regions.
Softness in construction markets: Continued weakness in construction markets has negatively impacted sales in the Building Technologies segment, posing a challenge to growth in this area.
Currency fluctuations: A stronger U.S. dollar has reduced the expected full-year currency benefit, creating headwinds for financial performance.
Geopolitical and macroeconomic headwinds: Potential macroeconomic and geopolitical uncertainties are acknowledged as risks that could impact productivity and operational resilience.
Full Year 2026 Financial Guidance: DuPont has raised its full-year 2026 financial guidance due to strong first-quarter performance and price increases related to the Middle East conflict. The company now expects net sales of approximately $7.185 billion, reflecting 4% organic growth, including 1% from pricing actions. Operating EBITDA is projected at $1.745 billion, and adjusted EPS is expected to range between $2.35 and $2.40 per share, a $0.10 increase from prior guidance.
Second Quarter 2026 Guidance: Net sales are estimated at approximately $1.8 billion, with operating EBITDA of about $430 million and adjusted EPS of $0.59 per share. Organic sales growth is expected to be 3% year-over-year, with mid-single-digit growth in the Healthcare & Water segment and low single-digit growth in the Diversified Industrial segment.
Healthcare & Water Segment Outlook: For the second quarter, organic sales growth is projected in the mid-single digits, driven by strength in medical device, biopharma, and industrial water markets. Full-year growth is expected to be supported by these trends.
Diversified Industrial Segment Outlook: Second-quarter organic sales growth is expected in the low single digits, with continued strength in aerospace and growth in printing and packaging, partially offset by ongoing softness in construction markets.
Currency and Pricing Impact: The full-year guidance includes a reduced currency benefit of less than 1% due to a stronger U.S. dollar and pricing actions to offset higher input costs caused by the Middle East conflict.
Accelerated Share Repurchase Program: DuPont announced the launch of a $275 million accelerated share repurchase under its existing program. This initiative is part of the company's strategic priority to drive disciplined capital allocation by returning cash to shareholders.
The earnings call summary presents mixed signals. Positive elements include strong margins, productivity gains, and strategic positioning in the healthcare and automotive segments. However, concerns arise from flat organic sales, construction market weakness, and uncertainties related to Middle East logistics. The Q&A section revealed management's avoidance of addressing potential demand destruction. These factors balance out, suggesting a neutral stock price reaction.
The earnings call summary and Q&A session reveal strong financial metrics, optimistic guidance, and positive shareholder returns, including a $2 billion share repurchase plan. Despite some concerns about regional sales and margin details, the overall sentiment is positive with raised guidance and strategic initiatives like the reverse osmosis expansion in China. These factors suggest a likely positive stock price movement in the short term.
The company raised its earnings guidance, announced a significant share repurchase plan, and demonstrated strong performance in key sectors like healthcare and water. The Q&A revealed operational excellence initiatives and a robust M&A pipeline, further supporting growth. Although there are some uncertainties, such as the timing benefit and construction market outlook, the overall sentiment is positive, with strong management confidence in achieving growth targets.
DuPont's earnings call indicates a positive sentiment with strong growth expectations in healthcare and water, a well-positioned electronics segment, and a strategic focus on M&A in fragmented markets. The Qnity spin-off and effective tariff mitigation further boost confidence. Despite some uncertainties, such as the Aramids divestment, the overall outlook is optimistic, suggesting a positive stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.